Daily deal net: February 4, 2021

Resilient Biotics, a US-based developer of microbiome-based treatments for respiratory infections in animals, has raised $7.1m in a series A round co-led by Berkeley Catalyst Fund, a venture unit aligned to University of California (UC) Berkeley, according to AgFunderNews. Fulcrum Global Capital co-led the round, which also included veterinary medicine producer Elanco Animal Health as well as Innovation in Motion and Viking Global Investors.
B Dot Medical, a Japan-based proton beam therapy developer, had raised a total of ¥700m ($6.7m) in series A funding from investors including Keio University’s Keio Innovation Initiative as of the end of last month, it disclosed on Tuesday. The round also features medical equipment importer Mediark, capacitor manufacturer Nichicon, radiotherapy and nuclear technology provider Cosylab and leasing service JA Mitsui Leasing. B Dot’s technology was created at Japan’s National Institute of Radiological Sciences.
Eurekite, a Netherlands-based spinout of University of Twente that has created a flexible ceramic fibre material called Flexiramics, received €4.2m ($5.1m) on Monday in a round featuring equity funding from electronic product manufacturer Demcon, Lumana Invest and Oost NL’s Innovation Fund Twente, debt financing from RVO and an equipment lease facility from High Tech Fund. The company said it had raised a total of €2.75m from Cottonwood Technology Fund between 2015 and 2020, including $1.3m in seed capital in 2015.
C Light Technologies, a US-based neurological health assessment tools developer, has received $2.5m in seed capital in a round backed by Berkeley Skydeck Fund, the investment vehicle for UC Berkeley’s incubator Skydeck, and led by Creative Ventures. The round also featured Yamaha Motor Ventures, the corporate venturing arm of motorcycles manufacturer Yamaha Motors, as well as Wisconsin Investment Partners, Band of Angels, EGB Capital, Monde Green Ventures, Puck Ventures and Vectors Angel Group. The company has now raised approximately $2.8m in capital, it said, and an additional $475,000 in grant funding. C Light has developed a retinal eye tracker to understand brain health, with an initial focus on multiple sclerosis.
Triditive, a Spain-based industrial additive manufacturing automation technology spinout of University of Oviedo, has raised $1.8m in seed funding from Stanley Ventures, the corporate venture capital arm of hardware product maker Stanley Black & Decker, as well as Techstars, Spanish government-owned fund Hunosa Empresas, accelerator CEEI Asturias’ Cuarta Financiación programme, Asturian regional government-owned Institute of Economic Development and assorted angel investors.
Charco Neurotech, a UK-based company working on a non-invasive medical device to help manage symptoms of Parkinson’s disease, secured £500,000 ($680,000) in seed funding, including $280,000 from the Imperial College Investment Fund. The deal marks the fund’s first investment. The vehicle focuses on companies with a strong connection to Imperial College London, and Charco Neurotech was founded by then-postgraduate student, Lucy Jung who was studying on a joint programme with Royal College of Art. Charco’s inaugural device, Cue1, is worn on the chest to help Parkinson’s patients walk and move their hands more easily. Investors in the round also included Royal College of Art, Amadeus Capital Partners, Crista Galli Ventures and Oxbridge Angels.
Cresta, a US-based spinout of Stanford University that has created a real-time customer support platform to help staff respond efficiently to clients, has secured an undisclosed amount of funding from Porsche Ventures, the corporate venturing arm of carmaker Porsche that will roll out the software across subsidiaries Porsche Cars North America and Porsche Financial Services. Cresta launched in February 2020 with $21m in funding from Greylock Partners, Andreessen Horowitz, Andy Bechtolsheim, Mark Leslie and Vivi Nevo.
– Additional reporting by Liwen-Edison Fu and Robert Lavine